View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Dexamethasone (20/20) / Cyclophosphamide 300 / Daratumumab 1800 / Bortezomib 1.3, AL amyloidosis, cycle 1-2
Protocol-ID: 1631 V1.1 (Mini), DEXA(20/20)/CYCL300/DRTM1800/BORT1,3, AL amyloidosis, C1-2Indication(s)
- Amyloidosis (AL Amyloidosis); ICD-10 E85.-
Links
- Daratumumab: Risiko der Reaktivierung von Hepatitis B [BfARM Risikoinf. Rote Hand etc.]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 12.10.2021